Key considerations include renal function, gastrointestinal health, and the patients overall medication regimen
If you have any risk factors for any of the conditions these drugs can prevent, Im going to do everything I can to get you on these medications, because to me, it would be inappropriate not to
Jan 5 2019;11(1)doi:10.3390/nu11010093 Jin JW, Inoue O, Suzuki-Inoue K, et al
It wasnt all bad news, with an extremely strong launch for the Wegovy pill, and a reminder of strong clinical progress in the next-generation pipeline at the tail-end of 2025. In London, Britains second-biggest drugmaker, GSK, said sales growth would slow to between 3% and 5% this year, from 7% growth to 32.7bn last year